Abstract
Seprafilm becomes brittle and sticky after contact with water, rendering it difficult to use in laparoscopic surgery. Hence, Seprafilm is not used frequently in laparoscopic surgery. This prospective randomized controlled trial aimed to compare the feasibility of two methods of application of Seprafilm: wet and non-wet. Two groups comprised 30 patients, each with 180 pieces of Seprafilm. Symptomatic patients who underwent laparoscopic surgeries, including hysterectomy and adnexal surgeries, were recruited. Successful application of Seprafilm was defined as a smooth attachment to the site of application. Sticky and fractured Seprafilm sheets were defined as failed applications. Between March 2016 and December 2017, 60 patients underwent laparoscopic Seprafilm placement. The preparation time was 32.67 ± 16.63 and 79.50 ± 22.01 s in the non-wet and wet groups, respectively (p < 0.00). The success rate of application was 95.4% in the non-wet group and 98.3% in the wet group (p = 0.09). Placement time was 599.50 ± 90.18 s and 592.53 ± 105.82 s in the non-wet and wet groups, respectively (p = 0.25). In conclusion, the wet and non-wet application methods of Seprafilm were feasible in laparoscopic surgeries. The preparation time was different between the two groups. However, the rate of successful application and placement time was not different between the two groups.
Reference14 articles.
1. A Prospective, Randomized, Multicenter, Controlled Study of the Safety of Seprafilm® Adhesion Barrier in Abdominopelvic Surgery of the Intestine
2. Prevention of Postoperative Abdominal Adhesions by a Sodium Hyaluronate-Based Bioresorbable Membrane: A Prospective, Randomized, Double-Blind Multicenter Study;Becker;J. Am. Coll. Surg.,1996
3. Reduction of adhesions after uterine myomectomy by Seprafilm* membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study †‡*Seprafilm, Genzyme Corporation, Cambridge, Massachusetts.†Sponsored by Genzyme Corporation, Cambridge, Massachusetts.‡Presented in part at the Fourth Congress of the Society for Gynecological Endoscopy, Brussels, Belgium, December 6 to 9, 1995.
4. Seprafilm Does Not Aggravate Intraperitoneal Septic Conditions or Evoke Systemic Inflammatory Response
5. Preventing Adhesions in Obstetric and Gynecologic Surgical Procedures;González-Quintero;Rev. Obstet. Gynecol.,2009